Sunesis Pharmaceuticals, Inc. Gains 24.3%
Fri, Feb 26, 2021 at 05:30 PM
Sunesis Pharmaceuticals, Inc. (SNSS:NASDAQ) jumped higher at $5.32, a gain of 24.3%. The stock appeared on our News Catalysts scanner on Wed 24 Feb 21 at 04:49 PM in the 'MERGER' category. From Thu 11 Feb 21, the stock recorded 55.56% Up Days and 50.00% Green Days
The stock spiked on Wed 24 Feb 21 at $7.09 with a volume of 70M+.
About Sunesis Pharmaceuticals, Inc. (SNSS:NASDAQ)
Sunesis Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers.
Top 10 Gainers:
- Xtant Medical Holdings, Inc. (XTNT:NYSEMKT), 124.35%
- Ocugen, Inc. (OCGN:NASDAQ), 36.88%
- FSR (FSR:NYSE), 32.07%
- Rubius Therapeutics, Inc. (RUBY:NASDAQ), 29.43%
- Armstrong Flooring, Inc. (AFI:NYSE), 28.22%
- Sunesis Pharmaceuticals, Inc. (SNSS:NASDAQ), 24.3%
- AMC Networks Inc. (AMCX:NASDAQ), 23.59%
- Sensus Healthcare, Inc. (SRTS:NASDAQ), 19.95%
- QuickLogic Corporation (QUIK:NASDAQ), 19.95%
- Select Medical Holdings Corporation (SEM:NYSE), 18.45%